Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Child and Adolescent Psychiatry and Mental Health|March 22, 2025
Impaired sleep quality mediates the relationship between internet gaming disorder and conduct problems among adolescents: a three-wave longitudinal studyPu Peng, Jieyin Jin, Zhangming Chen, et al.
International Journal of Antimicrobial Agents|September 18, 2024
The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trialNiandi Tan, Hao Wu, Cheng Lan, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2022
The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre studySongfeng Chen, Deliang Liu, Honghui Chen, et al.
Oncology Reports|August 2, 2018
Bioinformatic analysis suggests that UGT2B15 activates the Hippo‑YAP signaling pathway leading to the pathogenesis of gastric cancerXuanmin Chen, Defeng Li, Nannan Wang, et al.
BMC Cancer|October 2, 2023
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from ChinaHailu Sun, Aijun Liu, Lihong Liu, et al.
The Journal of Clinical Investigation|July 18, 2023
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulationMartina Cusan, Haifeng Shen, Bo Zhang, et al.
Frontiers in Oncology|May 8, 2023
Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in ChinaZhe Zhuang, Ying Tian, Lei Shi, et al.
Blood|July 31, 2010
Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemiaXin Liu, Lindsay Ryland, Jun Yang, et al.
Blood Cancer Discovery|April 17, 2023
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLLYiming Wu, Meiling Jin, Mike Fernandez, et al.
Cancer|December 11, 2024
Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1Zhen Cai, Zhongjun Xia, Ai-Li He, et al.
Pageof 7